Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Gilead Sciences patents

Patents where

Current Assignee

Name

Gilead Sciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11344565 Methods for the preparation of ribosides	Patent 11344565 was granted and assigned to Gilead Sciences on May, 2022 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11344565	May 31, 2022
‌ US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs	Patent 11701372 was granted and assigned to Gilead Sciences on July, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11701372	July 18, 2023
‌ US Patent 11318119 HIV protease inhibitors	Patent 11318119 was granted and assigned to Gilead Sciences on May, 2022 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11318119	May 3, 2022
‌ US Patent 11787825 Therapeutic compounds for HIV virus infection	Patent 11787825 was granted and assigned to Gilead Sciences on October, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11787825	October 17, 2023
‌ US Patent 7258980 Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands	Patent 7258980 was granted and assigned to Gilead Sciences on August, 2007 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	7258980	August 21, 2007
‌ US Patent 10882851 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections	Patent 10882851 was granted and assigned to Gilead Sciences on January, 2021 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	10882851	January 5, 2021
‌ US Patent 11680064 Capsid inhibitors for the treatment of HIV	Patent 11680064 was granted and assigned to Gilead Sciences on June, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11680064	June 20, 2023
‌ US Patent 11833143 Choline salt forms of an HIV capsid inhibitor	Patent 11833143 was granted and assigned to Gilead Sciences on December, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11833143	December 5, 2023
‌ US Patent 11780844 Compounds and methods for treatment of viral infections	Patent 11780844 was granted and assigned to Gilead Sciences on October, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11780844	October 10, 2023
‌ US Patent 9259426 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections	Patent 9259426 was granted and assigned to Gilead Sciences on February, 2016 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	9259426	February 16, 2016
‌ US Patent 8673929 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections	Patent 8673929 was granted and assigned to Gilead Sciences on March, 2014 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	8673929	March 18, 2014
‌ US Patent 11597742 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate	Patent 11597742 was granted and assigned to Gilead Sciences on March, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11597742	March 7, 2023
‌ US Patent 10059716 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections	Patent 10059716 was granted and assigned to Gilead Sciences on August, 2018 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	10059716	August 28, 2018
‌ US Patent 8716264 Compositions and methods for combination antiviral therapy	Patent 8716264 was granted and assigned to Gilead Sciences on May, 2014 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	8716264	May 6, 2014
‌ US Patent 11660307 Methods for treating SARS CoV-2 infections	Patent 11660307 was granted and assigned to Gilead Sciences on May, 2023 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11660307	May 30, 2023
‌ US Patent 7645747 Therapeutic phosphonate compounds	Patent 7645747 was granted and assigned to Gilead Sciences on January, 2010 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	7645747	January 12, 2010
‌ US Patent 10377761 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections	Patent 10377761 was granted and assigned to Gilead Sciences on August, 2019 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	10377761	August 13, 2019
‌ US Patent 9376441 Substituted pyrrolidines as SYK inhibitors	Patent 9376441 was granted and assigned to Gilead Sciences on June, 2016 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	9376441	June 28, 2016
‌ US Patent 10251898 Methods for treating Filoviridae virus infections	Patent 10251898 was granted and assigned to Gilead Sciences on April, 2019 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	10251898	April 9, 2019
‌ US Patent 10251904 Methods for treating arenaviridae and coronaviridae virus infections	Patent 10251904 was granted and assigned to Gilead Sciences on April, 2019 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	10251904	April 9, 2019
‌ US Patent 11491169 Remdesivir treatment methods	Patent 11491169 was granted and assigned to Gilead Sciences on November, 2022 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11491169	November 8, 2022
‌ US Patent 9951043 Therapeutic compounds	Patent 9951043 was granted and assigned to Gilead Sciences on April, 2018 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	9951043	April 24, 2018
‌ US Patent 11071730 Substituted 6-azabenzimidazole compounds	Patent 11071730 was granted and assigned to Gilead Sciences on July, 2021 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11071730	July 27, 2021
‌ US Patent 11203591 Substituted 6-azabenzimidazole compounds	Patent 11203591 was granted and assigned to Gilead Sciences on December, 2021 by the United States Patent and Trademark Office.	Gilead Sciences	Gilead Sciences	United States Patent and Trademark Office	11203591	December 21, 2021
‌ US Patent 7973013 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment	Patent 7973013 was granted and assigned to Gilead Sciences on July, 2011 by the United States Patent and Trademark Office.		Gilead Sciences	United States Patent and Trademark Office	7973013	July 5, 2011

...

Results per page:

670 results

0 selected

670 results

0 selected